Home Featured

Featured

Random

Psychedelics and Religion: A Short History

President Trump Signs Executive Order to Accelerate Psychedelic Research and Access

Algernon Pharmaceuticals Provides Update on Its Phase 1 DMT Stroke Study

Psychedelic Bulletin #108 – COMPASS Survives Patent Challenges; MindMed Secures Candyflipping IP; Will Psychedelics Companies Protect Access to Abortion for Employees?

The Great Reconnector: Finding Our Way Back Together With Psychedelics

Mindset Pharma Announces Development of Novel, Optimized, Intranasal Formulation

MIND CURE AND LNG ENERGY GROUP ENTER INTO ARRANGEMENT AGREEMENT WITH...

Reunion Neuroscience Inc. Obtains Final Court Order for Proposed Plan of Arrangement

Former Vancouver Firefighter Declares Psychedelic Drug Saved His Life

Mindset Pharma Strengthens IP Portfolio with Another New Provisional Patent Application...

Mindset Pharma Identifies New Pharmacological Insights of First Generation Psychedelics Through...

Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst...

MindMed Announces Appointment of Andreas Krebs and Carol Vallone as Directors...

Psyched Wellness Announces Matthew Singh Joins Team as CPG and Branding...

Algernon Pharmaceuticals Discloses Novel DMT Salt Patent Strategy Includes Bioactive Nicotinate...

12 3...323 Page 1 of 323

EDITOR PICKS

Field Notes #4: Resilient Refiles, Definium’s Readout, HRSA’s RFI Responses, and...

Weekly Psychedelic Policy Briefing – August 16, 2026

Horizons: Perspectives on Psychedelics

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.